CVA Family Office’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.9K | Sell |
201
-8
| -4% | -$2.06K | 0.01% | 541 |
|
|
2025
Q1 | $46.8K | Buy |
209
+48
| +30% | +$10.7K | 0.01% | 534 |
|
|
2024
Q4 | $36.8K | Buy |
161
+28
| +21% | +$6.4K | 0.01% | 576 |
|
|
2024
Q3 | $32.5K | Buy |
133
+20
| +18% | +$4.88K | 0.01% | 580 |
|
|
2024
Q2 | $21.6K | Hold |
113
| – | – | ﹤0.01% | 627 |
|
|
2024
Q1 | $22.4K | Buy |
113
+3
| +3% | +$594 | ﹤0.01% | 624 |
|
|
2023
Q4 | $18.9K | Buy |
+110
| New | +$18.9K | ﹤0.01% | 635 |
|
|
2023
Q3 | – | Sell |
-155
| Closed | -$33.9K | – | 789 |
|
|
2023
Q2 | $33.9K | Buy |
155
+40
| +35% | +$8.74K | 0.01% | 522 |
|
|
2023
Q1 | $25.2K | Sell |
115
-5
| -4% | -$1.1K | 0.01% | 552 |
|
|
2022
Q4 | $25K | Sell |
120
-90
| -43% | -$18.7K | 0.01% | 525 |
|
|
2022
Q3 | $46K | Buy |
210
+130
| +163% | +$28.5K | 0.01% | 391 |
|
|
2022
Q2 | $17K | Sell |
80
-70
| -47% | -$14.9K | ﹤0.01% | 568 |
|
|
2022
Q1 | $36K | Buy |
150
+30
| +25% | +$7.2K | 0.01% | 461 |
|
|
2021
Q4 | $31K | Buy |
+120
| New | +$31K | 0.01% | 449 |
|
|
2021
Q3 | – | Sell |
-120
| Closed | -$30K | – | 777 |
|
|
2021
Q2 | $30K | Buy |
120
+50
| +71% | +$12.5K | 0.01% | 440 |
|
|
2021
Q1 | $14K | Buy |
+70
| New | +$14K | 0.01% | 480 |
|